2m 2m 2m 2m 2m 2m 2m
Quest Diagnostic (DGX)
NYSE
$262.19+$3.50 (+1.35%)
Price as of Nov 12, 2026 8:56 AM EST- $28.6BMarket Cap
- 40.78%1-Year Change
- Diagnostics & ResearchIndustry
Quest Diagnostic (DGX)
$262.19+$3.50 (+1.35%)
DGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $258.69 | ||
Change | +$0.25 (+0.10%) | ||
Open | $256.84 | ||
High | $260.29 | ||
Low | $255.77 | ||
Previous Close | $258.44 | ||
Volume | 746,610 | ||
30-Day Average Volume | 989,749 | ||
1-Week Change | 1.18% | ||
1-Month Change | 12.00% | ||
1-Year Change | 40.78% | ||
3-Year Change | 106.13% | ||
5-Year Change | 92.20% | ||
Fundamentals | |||
Shares Outstanding | 110.4M | ||
Total Assets | $17.2B | ||
Market Cap | $28.6B | ||
Enterprise Value | $33.3B | ||
Period: QTR TTM FY | |||
Revenue | $3.1B | ||
Net Income | $312.0M | ||
Free Cash Flow | $445.0M | ||
EBIT | $472.0M | ||
EBITDA | $619.0M | ||
Net Working Capital | $1.3B | ||
EPS | $2.78 | ||
Enterprise Value/EBITDA | 54 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 4 | ||
P/E | 93 | ||
PEG | -44 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.33% | ||
Trailing Annual Dividend Yield | 1.31% | ||
Ex-Dividend Date | 01/12/2027 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 06/21/2005 | ||
Earnings & Revenue
Annual Dividend Yield